Tricyclic heterocyclic derivatives and uses thereof
申请人:AUCKLAND UNISERVICES LIMITED
公开号:US11028064B2
公开(公告)日:2021-06-08
Disclosed are tricyclic heterocyclic compounds having kinase inhibitory activity, pharmaceutical compositions and kits comprising the compounds, and use of the compounds in the treatment of or in medicaments for the treatment of various diseases and conditions. In particular, disclosed are tricyclic heterocyclic compounds of the formula (I) having CSF-1R (c-FMS kinase) inhibitory activity and their use in the treatment of various diseases and conditions, such as those mediated by CSF-1R, including proliferative or neoplastic diseases and conditions, including cancers, and bone, inflammatory, and autoimmune diseases and conditions.
TRICYCLIC HETEROCYCLIC DERIVATIVES AND USES THEREOF
申请人:Auckland Uniservices Limited
公开号:EP3535243A2
公开(公告)日:2019-09-11
SUBSTITUTED 9H-XANTHEN-9-ONE, 9H-THIOXANTHEN-9-ONE AND ACRIDIN-9(10H)-ONE DERIVATIVES AND RELATED COMPOUNDS CSF-1R INHIBITORS FOR THE TREATMENT OF CANCER